PITTSBURGH, Oct. 10,
2023 /PRNewswire/ -- Viatris Inc. (NASDAQ:
VTRS) plans to release its third quarter 2023 financial results on
Tuesday, November 7 after the close
of the U.S. financial markets. Chief Executive Officer Scott A. Smith, President Rajiv Malik, and Chief Financial
Officer Sanjeev
Narula also will host a webcast at 5:00 p.m. ET on
November 7 to discuss the
results.
Investors and the general public are invited to listen to a live
webcast of the call at investor.viatris.com or by calling
800.274.8461 or 203.518.9783 for international callers (Conference
ID: VTRSQ323). A replay of the webcast also will be available on
the website.
About Viatris
Viatris Inc.
(NASDAQ: VTRS) is a global healthcare
company uniquely positioned to bridge the traditional divide
between generics and brands, combining the best of both to more
holistically address healthcare needs globally. With a mission to
empower people worldwide to live healthier at every stage of life,
we provide access at scale. In 2022 alone, we supplied high-quality
medicines to approximately 1 billion patients around the world.
With our exceptionally extensive and diverse portfolio of
medicines, a one-of-a-kind global supply chain designed to reach
more people when and where they need them, and the scientific
expertise to address some of the world's most enduring health
challenges, access takes on deep meaning at Viatris.
We have the ability to touch all of life's moments, from birth to
end of life, acute conditions to chronic diseases. We are
headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more
at viatris.com and investor.viatris.com,
and connect with us on Twitter,
LinkedIn, Instagram and
YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/viatris-to-release-third-quarter-2023-financial-results-on-november-7-2023-301952330.html
SOURCE Viatris Inc.